| Literature DB >> 32338053 |
Muhammed Osman Corbali1, Ahmet Emre Eskazan2.
Abstract
Entities:
Keywords: AML; MDM2 inhibitor; TP53; acute myeloid leukemia; idasanutlin; relapsed or refractory
Year: 2020 PMID: 32338053 DOI: 10.2217/fon-2020-0218
Source DB: PubMed Journal: Future Oncol ISSN: 1479-6694 Impact factor: 3.404